Abstract:Background: C-X-C motif ligand 8 (CXCL8), known as a proinflammatory chemokine, exerts multiple effects on the proliferation, invasion, and migration of tumor cells via the autocrine or paracrine manner. Conversely, the human Dachshund homologue 1 (DACH1) is recognized as a tumor suppressor which retards the progression of various cancers. In prostate cancer, it has been demonstrated that DACH1 was negatively correlated with the expression of CXCL8 and able to antagonize the effects of CXCL8 on cellular migration. Herein, we explored the mechanisms by which DACH1 regulated the CXCL8 in non-small cell lung cancer (NSCLC). Methods: Public microarray and Kaplan-Meier plotter datasets were analyzed. Blood serum samples from lung adenocarcinoma (ADC) patients were collected for enzyme-linked immunosorbent assay (ELISA) analysis. Immunohistochemical staining was conducted on tissue microarray. Cell lines with stable expression of DACH1 were established, and relative gene expression was measured by Western blot, ELISA, real-time PCR, and human cytokine array. Correspondingly, cell lines transfected with shDACH1 were established, and relative gene expression was measured by real-time PCR and immunofluorescence array. Functional studies were performed by transwell and xenograft mice models. Luciferase reporter gene assay was applied to measure the regulation of DACH1 on CXCL8. Results: Our study indicated that CXCL8 both at the mRNA and protein level was associated with the high tumor burden of ADC. Correlational analyses in ADC cell lines and ADC tissues showed that DACH1 was inversely correlated with CXCL8. Meanwhile, patients with high DACH1 expression and low CXCL8 expression had prolonged time to death and recurrence. Moreover, we verified the inhibitory effects of DACH1 on CXCL8 both in vitro and in vivo. Mechanism studies proved that DACH1 transcriptionally repressed CXCL8 promoter activity through activator protein-1 (AP-1) and nuclear transcription factor-kappa B (NF-κB) sites. Conclusions: Our study proved that CXCL8 acted as an unfavorable factor promoting to tumor progression and poor prognosis of ADC, while DACH1 antagonized CXCL8 to provide a favorable survival of ADC patients. Double detection of DACH1 and CXCL8 may provide a precise information for further evaluating the prognosis of ADC patients.

DAX1 Promotes Cervical Cancer Cell Growth and Tumorigenicity Through Activation of Wnt/β-catenin Pathway Via GSK3β.

DAXX Inhibits Cancer Stemness and Epithelial–mesenchymal Transition in Gastric Cancer

Death Domain-associated Protein DAXX Promotes Ovarian Cancer Development and Chemoresistance*

Opposing biological functions of the cytoplasm and nucleus DAXX modified by SUMO-2/3 in gastric cancer

FOXC1 Negatively Regulates DKK1 Expression to Promote Gastric Cancer Cell Proliferation Through Activation of Wnt Signaling Pathway

ASF1b is a Novel Prognostic Predictor Associated with Cell Cycle Signaling Pathway in Gastric Cancer

942 Epigenetic Silencing of DACH1 Induces the Invasion and Migration of Gastric Cancer by Activating TGF-β Signaling

DAXX Promotes Ovarian Cancer Ascites Cell Proliferation and Migration by Activating the ERK Signaling Pathway.

A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression

Ezh2-Mediated Repression Of Gsk-3 Beta And Tp53 Promotes Wnt/Beta-Catenin Signaling-Dependent Cell Expansion In Cervical Carcinoma

Oncogenic Function of DACT1 in Colon Cancer Through the Regulation of Β-Catenin.

EZH2-mediated Repression of GSK-3β and TP53 Promotes Wnt/β-catenin Signaling-Dependent Cell Expansion in Cervical Carcinoma.

DAXX drives de novo lipogenesis and contributes to tumorigenesis

Dact1, An Antagonist To Wnt/Beta-Catenin Signaling, Suppresses Tumor Cell Growth And Is Frequently Silenced In Breast Cancer

Death Domain-Associated Protein Promotes Colon Cancer Metastasis Through Direct Interaction with ZEB1

TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer

DACT1 , an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer

Pan-cancer analysis identifies RNA helicase DDX1 as a prognostic marker

MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21cip1

Dach1 Is A Novel Predictive And Prognostic Biomarker In Hepatocellular Carcinoma As A Negative Regulator Of Wnt/Beta-Catenin Signaling

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis